In support of this idea, deletion of IL-4 in Tbkbp1-KO mice, which blocked hyper-production of memory-like CD8+ T cells (Supplementary Fig. 3e), abrogated their ability to mediate stronger tumor rejection and CD8+ effector T cell responses (Supplementary Fig. 4a–c). This evidence concerns the gene TBKBP1 and neoplasm.